Tag: Medtronic
In brief: Conduit Health’s raise, Quipt’s new phase, MiniMed’s debut
March 17, 2026HME News Staff
NEW YORK – Conduit Health, a consumer-oriented provider of insurance-covered medical supplies and services for Medicare and Medicaid patients, has announced a $17 million Series A to expand its vertically-integrated model that it says brings clinical care, insurance authorization and medical supply fulfillment together under one coordinated structure.
In just 16 months since its public launch, Conduit has delivered supplies to more than 50,000 patients, while increasing its product catalog...
Medtronic’s MiniMed joins Nasdaq
March 17, 2026HME News Staff
GALWAY, Ireland, and NORTHRIDGE, Calif. – MiniMed Group, a subsidiary of Medtronic, has begun trading on the Nasdaq under the ticker symbol “MMED” in connection with its initial public offering (IPO). "Today marks an exciting milestone for both MiniMed and Medtronic,” said Geoff Martha, Medtronic chairman and CEO. “Despite a challenging market backdrop shaped by geopolitical uncertainty, the teams successfully executed an oversubscribed offering and the second largest...
In brief: Medicare comparison legislation, Omnipod expansion, Owlet partnership
February 18, 2026HME News Staff
WASHINGTON — Senator Tim Scott, R-S.C., has introduced the Apples to Apples Comparison Act of 2026, which seeks to require the Centers for Medicare and Medicaid Services (CMS) to provide seniors with clear, comparable data when choosing between Medicare Advantage (MA) and traditional fee-for-service coverage. By giving seniors accurate cost and coverage information, the legislation empowers them to choose the plan that best meets their health care needs. “Seniors...
Medtronic reports Q3 earnings, sees diabetes growth
February 17, 2026HME News Staff
GALWAY, Ireland – Medtronic reported revenue of $9 billion for its third quarter of fiscal year 2026 (FY26), which ended Jan. 23, 2026. Of that, diabetes business revenue was $796 million, an increase of 14.8% as reported and 8.3% organic, led by double-digit strength in international markets. In May 2025, Medtronic announced it would separate its diabetes business into a new standalone company, which represented 8% of revenue and 4% of segment operating profit...
In brief: Cardinal, Medtronic stand up Rx channels for diabetes
January 13, 2026HME News Staff
DUBLIN, Ohio – Cardinal Health has introduced ContinuCare Pathway, a pharmacy-to-supplier referral pathway program designed to help retail pharmacies seamlessly refer patients to Cardinal Health at-Home Solutions for the fulfillment and home delivery of diabetes supplies, including continuous glucose monitors (CGMs).
“Providing diabetic supplies to patients covered under a medical benefit can create administrative burden on a pharmacy,” said Rob Schlissberg,...
Medtronic builds pharmacy channel for MiniMed insulin pump
January 12, 2026HME News Staff
MINNEAPOLIS – Medtronic Diabetes has expanded U.S. pharmacy formulary access for its MiniMed 780F insulin pump through agreements with major pharmacy benefit managers (PBMs) and group purchasing organizations (GPOs), including Ascent and Zinc.
These agreements also include access to the company's expanded CGM portfolio – Simplera sensor, Simplera Sync sensor, and Instinct sensor, made by Abbott – and build...
Medtronic starts IPO process for MiniMed
December 23, 2025HME News Staff
GALWAY, Ireland – Medtronic has announced that its diabetes business, which will operate under the name MiniMed, has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) for a proposed initial public offering (IPO) of newly issued common stock. The separation is expected to be completed through a series of capital markets transactions, with a preferred path of an IPO and subsequent split-off. MiniMed intends...
In brief: CQRC on CBP, WellSky on CarePort-Epic integration, Medtronic on new diabetes lead
December 11, 2025HME News Staff
WASHINGTON – The Council for Quality Respiratory Care (CQRC) commends the Centers for Medicare & Medicaid Services (CMS) for not including supplemental oxygen and continuous positive airway pressure (CPAP) devices and supplies in the next round of the competitive bidding program (CBP). Listening to concerns outlined by the CQRC and other oxygen stakeholders, Medicare’s decision to omit the products will lock in previous savings, while protecting patient...
Medtronic announces executive changes
December 10, 2025HME News Staff
GALWAY, Ireland – Medtronic has announced that Ryan Weispfenning, vice president and head of investor relations, will join its diabetes business to establish and lead the investor relations function for MiniMed, the planned new diabetes company. He brings more than 25 years of experience with Medtronic to his new role. “After leading Medtronic investor relations for the past decade, I am now honored to help...
In brief: PBM reform bill, dual-eligible data book, OSA-insomnia link
December 5, 2025HME News Staff
WASHINGTON – U.S. Senate Finance Committee Chairman Mike Crapo, R-Idaho, and Ranking Member Ron Wyden, D-Ore., have introduced the Pharmacy Benefit Manager (PBM) Price Transparency and Accountability Act to fix market distortions and increase transparency in federal prescription drug programs to lower patient costs at the pharmacy counter.
“Pharmacy benefit managers should not profit from overcharging patients for their prescriptions,” said...